Free Trial

Alpha Pro Tech (APT) Competitors

Alpha Pro Tech logo
$5.97 -0.51 (-7.93%)
As of 09:58 AM Eastern
This is a fair market value price provided by Massive. Learn more.

APT vs. KRMD, SMTI, HYPR, PDEX, and STEX

Should you be buying Alpha Pro Tech stock or one of its competitors? The main competitors of Alpha Pro Tech include KORU Medical Systems (KRMD), Sanara MedTech (SMTI), Hyperfine (HYPR), Pro-Dex (PDEX), and Biosig Technologies (STEX). These companies are all part of the "medical equipment" industry.

How does Alpha Pro Tech compare to KORU Medical Systems?

Alpha Pro Tech (NYSE:APT) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap medical equipment companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations, earnings and media sentiment.

Alpha Pro Tech has a net margin of 6.99% compared to KORU Medical Systems' net margin of -5.27%. Alpha Pro Tech's return on equity of 6.70% beat KORU Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Pro Tech6.99% 6.70% 5.76%
KORU Medical Systems -5.27%-13.66%-8.46%

22.7% of Alpha Pro Tech shares are owned by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are owned by institutional investors. 15.0% of Alpha Pro Tech shares are owned by company insiders. Comparatively, 18.5% of KORU Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, KORU Medical Systems had 7 more articles in the media than Alpha Pro Tech. MarketBeat recorded 8 mentions for KORU Medical Systems and 1 mentions for Alpha Pro Tech. KORU Medical Systems' average media sentiment score of 0.28 beat Alpha Pro Tech's score of 0.00 indicating that KORU Medical Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alpha Pro Tech
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
KORU Medical Systems
1 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Alpha Pro Tech has a beta of 0.8, meaning that its stock price is 20% less volatile than the S&P 500. Comparatively, KORU Medical Systems has a beta of 0.43, meaning that its stock price is 57% less volatile than the S&P 500.

KORU Medical Systems has a consensus target price of $7.25, suggesting a potential upside of 63.29%. Given KORU Medical Systems' stronger consensus rating and higher possible upside, analysts clearly believe KORU Medical Systems is more favorable than Alpha Pro Tech.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Pro Tech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
KORU Medical Systems
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60

Alpha Pro Tech has higher revenue and earnings than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than Alpha Pro Tech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Pro Tech$59.14M1.12$4.19M$0.3419.06
KORU Medical Systems$41.13M5.03-$2.64M-$0.06N/A

Summary

Alpha Pro Tech and KORU Medical Systems tied by winning 8 of the 16 factors compared between the two stocks.

How does Alpha Pro Tech compare to Sanara MedTech?

Sanara MedTech (NASDAQ:SMTI) and Alpha Pro Tech (NYSE:APT) are both small-cap medical equipment companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, profitability, institutional ownership, analyst recommendations, dividends, media sentiment and earnings.

Sanara MedTech presently has a consensus price target of $34.00, suggesting a potential upside of 78.20%. Given Sanara MedTech's stronger consensus rating and higher probable upside, research analysts plainly believe Sanara MedTech is more favorable than Alpha Pro Tech.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sanara MedTech
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
Alpha Pro Tech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Alpha Pro Tech has lower revenue, but higher earnings than Sanara MedTech. Sanara MedTech is trading at a lower price-to-earnings ratio than Alpha Pro Tech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sanara MedTech$103.12M1.69-$37.56M-$4.23N/A
Alpha Pro Tech$59.14M1.12$4.19M$0.3419.06

Sanara MedTech has a beta of 1.16, indicating that its stock price is 16% more volatile than the S&P 500. Comparatively, Alpha Pro Tech has a beta of 0.8, indicating that its stock price is 20% less volatile than the S&P 500.

Alpha Pro Tech has a net margin of 6.99% compared to Sanara MedTech's net margin of -36.42%. Alpha Pro Tech's return on equity of 6.70% beat Sanara MedTech's return on equity.

Company Net Margins Return on Equity Return on Assets
Sanara MedTech-36.42% -20.73% -5.14%
Alpha Pro Tech 6.99%6.70%5.76%

In the previous week, Sanara MedTech had 4 more articles in the media than Alpha Pro Tech. MarketBeat recorded 5 mentions for Sanara MedTech and 1 mentions for Alpha Pro Tech. Sanara MedTech's average media sentiment score of 0.15 beat Alpha Pro Tech's score of 0.00 indicating that Sanara MedTech is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sanara MedTech
0 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Alpha Pro Tech
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

8.1% of Sanara MedTech shares are owned by institutional investors. Comparatively, 22.7% of Alpha Pro Tech shares are owned by institutional investors. 42.0% of Sanara MedTech shares are owned by insiders. Comparatively, 15.0% of Alpha Pro Tech shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Sanara MedTech beats Alpha Pro Tech on 9 of the 16 factors compared between the two stocks.

How does Alpha Pro Tech compare to Hyperfine?

Hyperfine (NASDAQ:HYPR) and Alpha Pro Tech (NYSE:APT) are both small-cap medical equipment companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, profitability, institutional ownership, analyst recommendations, dividends, media sentiment and earnings.

Hyperfine presently has a consensus price target of $1.59, suggesting a potential downside of 5.51%. Given Hyperfine's stronger consensus rating and higher probable upside, research analysts plainly believe Hyperfine is more favorable than Alpha Pro Tech.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hyperfine
1 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.33
Alpha Pro Tech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Alpha Pro Tech has higher revenue and earnings than Hyperfine. Hyperfine is trading at a lower price-to-earnings ratio than Alpha Pro Tech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hyperfine$11.40M14.44-$35.57M-$0.44N/A
Alpha Pro Tech$59.14M1.12$4.19M$0.3419.06

Hyperfine has a beta of 1.42, indicating that its stock price is 42% more volatile than the S&P 500. Comparatively, Alpha Pro Tech has a beta of 0.8, indicating that its stock price is 20% less volatile than the S&P 500.

Alpha Pro Tech has a net margin of 6.99% compared to Hyperfine's net margin of -262.29%. Alpha Pro Tech's return on equity of 6.70% beat Hyperfine's return on equity.

Company Net Margins Return on Equity Return on Assets
Hyperfine-262.29% -95.09% -71.11%
Alpha Pro Tech 6.99%6.70%5.76%

In the previous week, Hyperfine had 3 more articles in the media than Alpha Pro Tech. MarketBeat recorded 4 mentions for Hyperfine and 1 mentions for Alpha Pro Tech. Hyperfine's average media sentiment score of 0.38 beat Alpha Pro Tech's score of 0.00 indicating that Hyperfine is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hyperfine
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Alpha Pro Tech
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

15.0% of Hyperfine shares are owned by institutional investors. Comparatively, 22.7% of Alpha Pro Tech shares are owned by institutional investors. 26.3% of Hyperfine shares are owned by insiders. Comparatively, 15.0% of Alpha Pro Tech shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Hyperfine and Alpha Pro Tech tied by winning 8 of the 16 factors compared between the two stocks.

How does Alpha Pro Tech compare to Pro-Dex?

Pro-Dex (NASDAQ:PDEX) and Alpha Pro Tech (NYSE:APT) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, analyst recommendations, media sentiment, dividends, earnings and risk.

Pro-Dex currently has a consensus price target of $56.00, suggesting a potential downside of 2.47%. Given Pro-Dex's stronger consensus rating and higher possible upside, analysts clearly believe Pro-Dex is more favorable than Alpha Pro Tech.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pro-Dex
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Alpha Pro Tech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

15.3% of Pro-Dex shares are owned by institutional investors. Comparatively, 22.7% of Alpha Pro Tech shares are owned by institutional investors. 45.9% of Pro-Dex shares are owned by insiders. Comparatively, 15.0% of Alpha Pro Tech shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Pro-Dex and Pro-Dex both had 1 articles in the media. Pro-Dex's average media sentiment score of 0.00 equaled Alpha Pro Tech'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Pro-Dex
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Alpha Pro Tech
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Pro-Dex has a net margin of 16.08% compared to Alpha Pro Tech's net margin of 6.99%. Pro-Dex's return on equity of 22.78% beat Alpha Pro Tech's return on equity.

Company Net Margins Return on Equity Return on Assets
Pro-Dex16.08% 22.78% 14.30%
Alpha Pro Tech 6.99%6.70%5.76%

Pro-Dex has a beta of -0.12, indicating that its share price is 112% less volatile than the S&P 500. Comparatively, Alpha Pro Tech has a beta of 0.8, indicating that its share price is 20% less volatile than the S&P 500.

Pro-Dex has higher revenue and earnings than Alpha Pro Tech. Pro-Dex is trading at a lower price-to-earnings ratio than Alpha Pro Tech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pro-Dex$74.64M2.46$8.98M$3.6215.86
Alpha Pro Tech$59.14M1.12$4.19M$0.3419.06

Summary

Pro-Dex beats Alpha Pro Tech on 11 of the 14 factors compared between the two stocks.

How does Alpha Pro Tech compare to Biosig Technologies?

Alpha Pro Tech (NYSE:APT) and Biosig Technologies (NASDAQ:STEX) are both small-cap medical equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, dividends, analyst recommendations and profitability.

Alpha Pro Tech has higher revenue and earnings than Biosig Technologies. Biosig Technologies is trading at a lower price-to-earnings ratio than Alpha Pro Tech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Pro Tech$59.14M1.12$4.19M$0.3419.06
Biosig Technologies$40K4,402.61-$462.77M-$9.58N/A

Alpha Pro Tech has a beta of 0.8, indicating that its share price is 20% less volatile than the S&P 500. Comparatively, Biosig Technologies has a beta of 1.58, indicating that its share price is 58% more volatile than the S&P 500.

In the previous week, Biosig Technologies had 4 more articles in the media than Alpha Pro Tech. MarketBeat recorded 5 mentions for Biosig Technologies and 1 mentions for Alpha Pro Tech. Biosig Technologies' average media sentiment score of 0.35 beat Alpha Pro Tech's score of 0.00 indicating that Biosig Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alpha Pro Tech
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Biosig Technologies
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Biosig Technologies has a consensus price target of $9.00, suggesting a potential upside of 825.74%. Given Biosig Technologies' stronger consensus rating and higher possible upside, analysts plainly believe Biosig Technologies is more favorable than Alpha Pro Tech.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Pro Tech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Biosig Technologies
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Alpha Pro Tech has a net margin of 6.99% compared to Biosig Technologies' net margin of 0.00%. Alpha Pro Tech's return on equity of 6.70% beat Biosig Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Pro Tech6.99% 6.70% 5.76%
Biosig Technologies N/A -1,476.78%-428.30%

22.7% of Alpha Pro Tech shares are held by institutional investors. Comparatively, 7.2% of Biosig Technologies shares are held by institutional investors. 15.0% of Alpha Pro Tech shares are held by company insiders. Comparatively, 52.7% of Biosig Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Alpha Pro Tech and Biosig Technologies tied by winning 8 of the 16 factors compared between the two stocks.

Get Alpha Pro Tech News Delivered to You Automatically

Sign up to receive the latest news and ratings for APT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding APT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

APT vs. The Competition

MetricAlpha Pro TechSurgical appliances & supplies IndustryIndustrials SectorNYSE Exchange
Market Cap$66.00M$27.77M$9.50B$23.22B
Dividend YieldN/AN/A3.56%4.01%
P/E Ratio17.5117.5125.4328.31
Price / Sales1.121.795,545.2124.53
Price / Cash12.8012.8027.5525.49
Price / Book1.221.844.754.67
Net Income$4.19M-$3.92M$792.42M$1.07B
7 Day PerformanceN/AN/AN/A-0.56%
1 Month Performance39.96%23.02%5.97%4.50%
1 Year Performance39.66%-26.41%40.50%28.67%

Alpha Pro Tech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
APT
Alpha Pro Tech
N/A$5.97
-7.9%
N/A+44.6%$62.52M$59.14M16.59120
KRMD
KORU Medical Systems
2.887 of 5 stars
$3.95
-1.1%
$6.50
+64.8%
+63.2%$183.88M$41.13MN/A80
SMTI
Sanara MedTech
1.7561 of 5 stars
$19.08
+0.4%
$34.00
+78.2%
-40.1%$174.73M$103.12MN/A60
HYPR
Hyperfine
1.886 of 5 stars
$1.75
+5.1%
$1.59
-9.0%
+137.1%$170.94M$13.56MN/A190
PDEX
Pro-Dex
0.9125 of 5 stars
$46.51
-7.2%
$56.00
+20.4%
+35.0%$150.81M$66.59M13.82140

Related Companies and Tools


This page (NYSE:APT) was last updated on 5/8/2026 by MarketBeat.com Staff.
From Our Partners